Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: the VELREAL multicentre study.
Juan Francisco Navarro-GonzálezMaría Dolores ArenasFernando Henríquez-PalopMaría Jesús LloretPablo MolinaFrancisco Ríos MorenoMaría Asunción Macia-LagierLaura EspinelEmilio SánchezMar LagoAntonio CrespoJordi BoverPublished in: Clinical kidney journal (2021)
The use of SO in real-life results in better control of serum P, a reduction in the number of tablets and an improvement in therapeutic adherence. In addition, it may be beneficial with regards to secondary hyperparathyroidism and nutritional status.